AdventHealthMD
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
In March, the U.S. Food and Drug Administration (FDA) granted...
An AdventHealth physician and team researched and developed a new brain-eating amoeba test that can produce results within three hours. Previously, testing routinely took up to six days, while the...
AdventHealth leader, Barry Friedman, testified in front of the U.S. Senate Finance Committee that the United Network for Organ Sharing (UNOS) has failed – and transplant surgeon Bobby Nibhanupudy, M.D...
As part of Healthcare Innovation’s Advancing Digital Healthcare Delivery, a monthly digital health virtual series with innovators who are transforming healthcare, Rajan Wadhawan, M.D., candidly...
Featuring: Regino P. Gonzalez-Peralta, MD and Stefany Hernanez-Benabe, MD
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.